Machine learning model to predict the fitness of AAV capsids for gene therapy
Peer-Reviewed Publication
Shawn Demehri, MD, PhD, a physician-investigator in the Cutaneous Biology Research Center and Krantz Family Center for Cancer Research at Massachusetts General Hospital and an Associate Professor of Dermatology at Harvard Medical School in the senior author of a new study in Cell Reports, Epigenomic Regulation of Stemness Contributes to the Low Immunogenicity of the Most Mutated Human Cancer.
Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS). The Consortium of Multiple Sclerosis Centers (CMSC) regularly publishes Best Practices statements on aspects of MS care. This month, a new “Best Practices in Multiple Sclerosis Therapies: 2025 Update” has been released on the organization’s website [https://www.mscare.org/best-practices-in-multiple-sclerosis-therapies/] and will be distributed at the upcoming CMSC Annual Meeting, May 28-31, 2025, in Phoenix, AZ. [www.mscare.org/2025]
How should we prioritize patients waiting for kidney transplants? A new study could help policymakers analyze methods of matching donated kidneys and their recipients.